1. Home
  2. HOTH vs HTCR Comparison

HOTH vs HTCR Comparison

Compare HOTH & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • HTCR
  • Stock Information
  • Founded
  • HOTH 2017
  • HTCR 2009
  • Country
  • HOTH United States
  • HTCR Japan
  • Employees
  • HOTH N/A
  • HTCR N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • HTCR EDP Services
  • Sector
  • HOTH Health Care
  • HTCR Technology
  • Exchange
  • HOTH Nasdaq
  • HTCR Nasdaq
  • Market Cap
  • HOTH 15.6M
  • HTCR 16.9M
  • IPO Year
  • HOTH 2019
  • HTCR 2022
  • Fundamental
  • Price
  • HOTH $1.60
  • HTCR $0.96
  • Analyst Decision
  • HOTH Strong Buy
  • HTCR
  • Analyst Count
  • HOTH 3
  • HTCR 0
  • Target Price
  • HOTH $4.00
  • HTCR N/A
  • AVG Volume (30 Days)
  • HOTH 1.8M
  • HTCR 2.4M
  • Earning Date
  • HOTH 11-11-2025
  • HTCR 11-13-2025
  • Dividend Yield
  • HOTH N/A
  • HTCR N/A
  • EPS Growth
  • HOTH N/A
  • HTCR N/A
  • EPS
  • HOTH N/A
  • HTCR N/A
  • Revenue
  • HOTH N/A
  • HTCR $29,625,381.00
  • Revenue This Year
  • HOTH N/A
  • HTCR N/A
  • Revenue Next Year
  • HOTH N/A
  • HTCR $3.52
  • P/E Ratio
  • HOTH N/A
  • HTCR N/A
  • Revenue Growth
  • HOTH N/A
  • HTCR 72.95
  • 52 Week Low
  • HOTH $0.65
  • HTCR $0.39
  • 52 Week High
  • HOTH $3.80
  • HTCR $3.38
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 71.15
  • HTCR 55.00
  • Support Level
  • HOTH $1.40
  • HTCR $0.84
  • Resistance Level
  • HOTH $1.80
  • HTCR $1.15
  • Average True Range (ATR)
  • HOTH 0.11
  • HTCR 0.23
  • MACD
  • HOTH 0.04
  • HTCR -0.02
  • Stochastic Oscillator
  • HOTH 68.75
  • HTCR 24.20

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: